Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 15771866)

1.

Personality and disease outcome in malignant melanoma.

Canada AL, Fawzy NW, Fawzy FI.

J Psychosom Res. 2005 Jan;58(1):19-27.

PMID:
15771866
2.
3.

Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.

Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL.

Arch Gen Psychiatry. 1993 Sep;50(9):681-9.

PMID:
8357293
4.

Psychological factors in the prognosis of malignant melanoma: a prospective study.

Rogentine GN Jr, van Kammen DP, Fox BH, Docherty JP, Rosenblatt JE, Boyd SC, Bunney WE Jr.

Psychosom Med. 1979 Dec;41(8):647-55.

PMID:
545425
5.

Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma.

Brown JE, Butow PN, Culjak G, Coates AS, Dunn SM.

Br J Cancer. 2000 Dec;83(11):1448-53.

6.

Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.

Piras F, Murtas D, Minerba L, Ugalde J, Floris C, Maxia C, Colombari R, Perra MT, Sirigu P.

Histopathology. 2007 Jun;50(7):835-42.

PMID:
17543072
7.

Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.

Doerler M, Hyun J, Venten I, Potthoff A, Bartke U, Serova K, Hoextermann S, Altmeyer P, Brockmeyer NH.

Eur J Med Res. 2007 Oct 30;12(10):497-502.

PMID:
18024256
8.

The influence of marital status on stage at diagnosis and survival of older persons with melanoma.

Reyes Ortiz CA, Freeman JL, Kuo YF, Goodwin JS.

J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):892-8.

PMID:
17702882
9.

Melanoma of the ear: prognostic factors and surgical strategies.

Jahn V, Breuninger H, Garbe C, Moehrle M.

Br J Dermatol. 2006 Feb;154(2):310-8.

PMID:
16433802
10.

Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study.

Boesen EH, Boesen SH, Frederiksen K, Ross L, Dahlstrøm K, Schmidt G, Naested J, Krag C, Johansen C.

J Clin Oncol. 2007 Dec 20;25(36):5698-703.

11.

Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients.

Brunner G, Reitz M, Schwipper V, Tilkorn H, Lippold A, Biess B, Suter L, Atzpodien J.

Cancer Biother Radiopharm. 2008 Aug;23(4):451-9. doi: 10.1089/cbr.2008.0473.

PMID:
18771349
12.

Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.

Mücke T, Hölzle F, Kesting MR, Loeffelbein DJ, Robitzky LK, Hohlweg-Majert B, Tannapfel A, Wolff KD.

J Oral Maxillofac Surg. 2009 Jul;67(7):1409-15. doi: 10.1016/j.joms.2008.12.021.

PMID:
19531410
14.

Baseline psychosocial predictors of survival in localized melanoma.

Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P.

J Psychosom Res. 2007 Jul;63(1):9-15.

PMID:
17586333
15.

Women and vulnerability to depression: some personality and clinical factors.

Carrillo JM, Rojo N, Staats AW.

Span J Psychol. 2004 May;7(1):29-39.

PMID:
15139246
16.

Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.

Bastiaannet E, Hoekstra OS, Oyen WJ, Jager PL, Wobbes T, Hoekstra HJ.

Ann Surg Oncol. 2006 Jul;13(7):919-26. Epub 2006 May 23.

PMID:
16788752
17.

KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.

Janku F, Novotny J, Julis I, Julisova I, Pecen L, Tomancova V, Kocmanova G, Krasna L, Krajsova I, Stork J, Petruzelka L.

Melanoma Res. 2005 Aug;15(4):251-6.

PMID:
16034302
18.

[Outcome of malignant melanoma in gastrointestinal tract: clinical analysis of 70 cases].

Li ZY, Cai JQ, Cui XZ, Shao YF, Jin YB.

Zhonghua Wai Ke Za Zhi. 2008 Apr 15;46(8):574-6. Chinese.

PMID:
18844049
19.

Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.

Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL Jr, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong SJ; Sentinel Lymph Node Working Group.

Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):370-3.

PMID:
16618904
20.

Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.

Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL.

Ann Surg Oncol. 2007 May;14(5):1604-11. Epub 2007 Mar 1.

PMID:
17333418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk